| Value | ₹128.0 Cr |
|---|
NSE filing, NSE: AWFIS. Summary written from the filing by ALFA Finder's alert engine.
Awfis Space Solutions Ltd: key numbers
- Share price
- ₹233.88
- Market cap
- ₹1,674 Cr
- Revenue (annual)
- ₹1,493 Cr
- Net profit (annual)
- ₹70.85 Cr
- P/E (TTM)
- 19.7×Sector 33.4×
- Promoter holding
- 17.00%+0.00% QoQ
- FII holding
- 25.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Awfis Space Solutions Ltd
All →Awfis Space Solutions Capacity Expansion
Awfis launched ~1,45,000 sq. ft. of premium workspaces across Pune, Bengaluru, and Mumbai. The expansion deepens its Grade A+ footprint in key metro cities.
- chargeable workspace area
- 145000 sq. ft.
Awfis Space Solutions Board Meeting Date
Awfis Space Solutions has scheduled a Board Meeting for November 3, 2026. The Board will approve Q1 and H1 FY27 unaudited financial results.
Awfis Space Solutions Other Announcement
Awfis Space Solutions Ltd filed a Regulation 74(5) certificate from its RTA, confirming the non-applicability of the regulation as all shares are held in dematerialized form.
Awfis Space Solutions Legal & Regulatory
Awfis Space Solutions received an adverse arbitral award of ₹8.26 crore. The company anticipates a net incremental cost impact not exceeding ₹6.3 crore.
- Value
- ₹8.26 Cr
Awfis Space Solutions Debt & Borrowing: ₹80 Cr
Awfis Space Solutions has availed debt facilities totalling INR 80 Crore from IDFC FIRST Bank Limited, comprising an overdraft and a corporate term loan.
- Value
- ₹80.00 Cr
- From
- IDFC FIRST Bank Limited
Awfis Space Solutions Capacity Expansion
Awfis launched its 9th Elite centre in Aerocity, New Delhi, adding ~1,00,000 sq. ft. of premium workspace. This expands its premium portfolio to 37 centres across India.
- workspace area
- 100000 sq. ft.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.